Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Photos: KC Coworking Day sings virtues of big ideas in startup spaces
KC Coworking Day is a celebration of people whose vision exceeds their circumstances, said Bob Martin. “If you’re an entrepreneur, and you have a vision, I hope your vision is so big that you’re uncomfortable sharing it with everybody — that there’s only a handful of people to whom you’re going to say, ‘This is…
Digital Sandbox startup Fast Democracy building non-partisan social database for tracking legislation
Today’s political climate demands not only a better-informed public, but accurate tools to help voters arm themselves with timely information, said Sara Baker, co-founder of Fast Democracy. The Kansas City-based startup — one of four early-stage businesses recently accepted into Digital Sandbox KC — aims to help people “touch their democracy” through its non-partisan web…
Tech Scouts: Your pitch ideas could help defend the US; Aug. 12 application deadline nears
The U.S. Department of Defense isn’t just bullets and bombs, said Jack Harwell. A five-day October event — “Encountering Innovation,” which is organized by the DoD and the Small Business Development Center’s Kansas office — gives entrepreneurs the opportunity to pitch innovative solutions to a panel of the DoD’s “tech scouts,” said Harwell, advisor at…
Flyover Capital celebrates $63 million sale of its second portfolio firm Agrible
In a deal that further validates the vibrancy of the Midwest tech scene, leaders at Kansas City-based Flyover Capital are lauding the sale of its second portfolio firm since its launch in 2014. Flyover — a venture capital firm whose mission is to fuel the next generation of tech startups in the Midwest — is…